Home › Funds › GILEAD SCIENCES, INC. › ASMB
GILEAD SCIENCES, INC. position in ASMB
Assembly Biosciences Inc. · Health Care
GILEAD SCIENCES, INC. reported holding 4,977,089 shares of ASMB (Assembly Biosciences Inc.) in its Q3 2026 13F filing — a position valued at US$116.9M, representing 7.99% of its reported portfolio and ranking #3 among its reported holdings. GILEAD SCIENCES, INC. has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How GILEAD SCIENCES, INC.'s ASMB position evolved
GILEAD SCIENCES, INC. first disclosed a stake in ASMB in Q4 2024 at 2,209,471 shares (US$34.9M). The position peaked in Q4 2025 at 4,505,391 shares, worth US$153.2M. Across 8 filings, GILEAD SCIENCES, INC. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 4,977,089 shares valued at US$116.9M. Notable position changes include a 104% increase in Q3 2025 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.21M | $34.87M | New |
| Q1 2025 | 2.21M | $21.12M | Hold |
| Q2 2025 | 2.21M | $40.04M | Hold |
| Q3 2025 | 4.51M | $115.34M | Add |
| Q4 2025 | 4.51M | $153.23M | Hold |
| Q1 2026 | 4.51M | $125.02M | Hold |
| Q2 2026 | 4.98M | $136.77M | Add |
| Q3 2026 | 4.98M | $116.91M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASMB and 13F data
ASMB (Assembly Biosciences Inc.) is a Health Care company. 59 other funds we track also report a position in ASMB — the largest reported positions include Farallon Capital Management (US$44.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$44.1M), Paradigm Biocapital Advisors LP (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASMB
- Farallon Capital Management 1.60M sh · $44.09M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.60M sh · $44.09M · Q2 2026
- Paradigm Biocapital Advisors LP 1.55M sh · $42.70M · Q2 2026
- Commodore Capital LP 1.42M sh · $38.88M · Q2 2026
- Parkman Healthcare Partners LLC 721.18K sh · $19.82M · Q2 2026
- Seven Fleet Capital Management LP 433.15K sh · $11.90M · Q2 2026
- DV EQUITIES, LLC 226.41K sh · $6.22M · Q2 2026
- B Group, Inc. 175.71K sh · $4.83M · Q2 2026
- STEMPOINT CAPITAL LP 170.38K sh · $4.68M · Q2 2026
- Squadron Capital Management LLC 160.00K sh · $4.40M · Q2 2026
- Ally Bridge Group (NY) LLC 140.00K sh · $3.85M · Q2 2026
More on GILEAD SCIENCES, INC.
FAQ
How long has GILEAD SCIENCES, INC. held ASMB?
GILEAD SCIENCES, INC. has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is GILEAD SCIENCES, INC.'s current position in ASMB?
As of Q3 2026, GILEAD SCIENCES, INC. holds 4.98M shares of ASMB (Assembly Biosciences Inc.), valued at $116.91M, representing 7.99% of its reported portfolio and ranking #3.
Has GILEAD SCIENCES, INC. been buying or selling ASMB?
In the latest 13F filing (Q3 2026), GILEAD SCIENCES, INC. held unchanged its position in ASMB. The position peaked in Q4 2025 at 4.51M shares.
Which other funds hold ASMB?
Other major institutional holders of ASMB include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Paradigm Biocapital Advisors LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.